Gut
Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study.
Jun Fang, Siyi Zhong, Tielong Wang, Kang He, Aibo Mu, Meiching Ong, Yimou Lin, Zebin Zhu, Ning Wang, Jiancheng Wu, Zhihao Wang, Zhao Li, Feng Gao, Li Zhuang, Zhiyong Guo
Published: 202510.1136/gutjnl-2025-336719
Abstract
BACKGROUND: Immune checkpoint inhibitors (ICIs) enable successful hepatocellular carcinoma (HCC) downstaging or bridging for liver transplantation (LT) but increase allograft rejection risk. Although immune-related adverse events (irAEs) reflect immu…
Preview only. Read the full abstract at the source